Implantica receives Frost & Sullivan’s 2022 European Technology Innovation Leadership Award for RefluxStop™ – an Innovative Treatment Solution for Acid Reflux
Implantica AG (publ), a med-tech company at the forefront of the upcoming eHealth revolution, announces today that Frost & Sullivan, world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, announced today that Implantica was named the winner of the 2022 European Technology Innovation Leadershiop Award for its novel RefluxStop™ technology treating gastroesophageal reflux disease (GERD).“Frost & Sullivan commends Implantica’s development of its groundreaking technology, RefluxStop™, a medical implant